An association study on ADAM10 promoter polymorphisms and atherosclerotic cerebral infarction in a chinese population

CNS Neuroscience and Therapeutics

Volumn 19, Issue 10, 2013, Pages 785-794

  Li, You ^a   Liao, Feng ^a   Yin, Xiao Jian ^a   Cui, Li Li ^a   Ma, Guo Da ^a   Nong, Xiao Xian ^a   Zhou, Hai Hong ^a   Chen, Yan Fang ^a,b   Zhao, Bin ^a   Li, Ke Shen ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

ADAM10; Atherosclerotic cerebral infarction; Polymorphism

Indexed keywords

ADAM10 ENDOPEPTIDASE; GENOMIC DNA; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC CEREBRAL INFARCTION; BRAIN ATHEROSCLEROSIS; BRAIN INFARCTION; CASE CONTROL STUDY; CHINESE; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEMOGRAPHY; DNA ISOLATION; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HUMAN; HUMAN CELL; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; ULTRASOUND SCANNER;

ADAM10; ATHEROSCLEROTIC CEREBRAL INFARCTION; POLYMORPHISM;

ADAM PROTEINS; AGED; AGED, 80 AND OVER; AMYLOID PRECURSOR PROTEIN SECRETASES; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROMOTER REGIONS, GENETIC;

EID: 84884815154     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/cns.12136     Document Type: Article

References (34)

1. Edwards DR, Handsley MM, Pennington CJ. The ADAM metalloproteinases. Mol Aspects Med 2008;29:258-289.
2. Dreymueller D, Pruessmeyer J, Groth E, Ludwig A. The role of ADAM-mediated shedding in vascular biology. Eur J Cell Biol 2012;91:472-485.
3. van der Vorst EP, Keijbeck AA, de Winther MP, Donners MM. A disintegrin and metalloproteases: Molecular scissors in angiogenesis, inflammation and atherosclerosis. Atherosclerosis 2012;224:302-308.
4. Murphy G. The ADAMs: Signalling scissors in the tumour microenvironment. Nat Rev Cancer 2008;8:929-941.
5. Duffy MJ, Mullooly M, O'Donovan N, et al. The ADAMs family of proteases: New biomarkers and therapeutic targets for cancer? Clin Proteomics 2011;8:9.
6. Pelisek J, Pongratz J, Deutsch L, Reeps C, Stadlbauer T, Eckstein HH. Expression and cellular localization of metalloproteases ADAMs in high graded carotid artery lesions. Scand J Clin Lab Invest 2012;72:648-656.
7. Hundhausen C, Misztela D, Berkhout TA, et al. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 2003;102:1186-1195.
8. Hikita A, Tanaka N, Yamane S, et al. Involvement of a disintegrin and metalloproteinase 10 and 17 in shedding of tumor necrosis factor-alpha. Biochem Cell Biol 2009;87:581-593.
9. Pruessmeyer J, Ludwig A. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer. Semin Cell Dev Biol 2009;20:164-174.
10. Donners MM, Wolfs IM, Olieslagers S, et al. A disintegrin and metalloprotease 10 is a novel mediator of vascular endothelial growth factor-induced endothelial cell function in angiogenesis and is associated with atherosclerosis. Arterioscler Thromb Vasc Biol 2010;30:2188-2195.
11. Zhang C, Tian L, Chi C, et al. Adam10 is essential for early embryonic cardiovascular development. Dev Dyn 2010;239:2594-2602.
12. Prinzen C, Muller U, Endres K, Fahrenholz F, Postina R. Genomic structure and functional characterization of the human ADAM10 promoter. FASEB J 2005;19:1522-1524.
13. Bekris LM, Lutz F, Li G, et al. ADAM10 expression and promoter haplotype in Alzheimer's disease. Neurobiol Aging 2012;33:2229 e2221-2229 e2229.
14. Jian XQ, Wang KS, Wu TJ, Hillhouse JJ, Mullersman JE. Association of ADAM10 and CAMK2A polymorphisms with conduct disorder: Evidence from family-based studies. J Abnorm Child Psychol 2011;39:773-782.
15. Kavanagh D, McKay GJ, Patterson CC, McKnight AJ, Maxwell AP, Savage DA. Association analysis of Notch pathway signalling genes in diabetic nephropathy. Diabetologia 2011;54:334-338.
16. Kim M, Suh J, Romano D, et al. Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity. Hum Mol Genet 2009;18:3987-3996.
17. Song JH, Yu JT, Liu M, Yan CZ, Tan L. Genetic association between ADAM10 gene polymorphism and Alzheimer's disease in a Northern Han Chinese population. Brain Res 2011;1421:78-81.
18. Adams HP Jr., Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
19. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
20. Saftig P, Reiss K. The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: Novel drug targets with therapeutic potential? Eur J Cell Biol 2011;90:527-535.
21. Schulz B, Pruessmeyer J, Maretzky T, et al. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin. Circ Res 2008;102:1192-1201.
22. Claesson-Welsh L. ADAM-mediated shedding, a new flavor in angiogenesis regulation. Arterioscler Thromb Vasc Biol 2010;30:2087-2088.
23. Rocks N, Paulissen G, El Hour M, et al. Emerging roles of ADAM and ADAMTS metalloproteinases in cancer. Biochimie 2008;90:369-379.
24. Bekris LM, Galloway NM, Millard S, et al. Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease. Neurobiol Aging 2011;32:556 e513-556 e523.
25. Wang YY, Ye ZY, Li L, Zhao ZS, Shao QS, Tao HQ. ADAM10 is associated with gastric cancer progression and prognosis of patients. J Surg Oncol 2011;103:116-123.
26. Armstrong C, Abilleira S, Sitzer M, Markus HS, Bevan S. Polymorphisms in MMP family and TIMP genes and carotid artery intima-media thickness. Stroke 2007;38:2895-2899.
27. Wilton SB, Kavanagh KM, Aggarwal SG, et al. Association of rate-controlled persistent atrial fibrillation with clinical outcome and ventricular remodelling in recipients of cardiac resynchronization therapy. Can J Cardiol 2011;27:787-793.
28. Polak JF, Pencina MJ, O'Leary DH, D'Agostino RB. Common carotid artery intima-media thickness progression as a predictor of stroke in multi-ethnic study of atherosclerosis. Stroke 2011;42:3017-3021.
29. Molinari F, Suri JS, Kathuria C. Atherosclerosis Disease Management. Germany: Springer, 2010. ISBN: 1-4419-7221-8
30. Ziegelbauer K, Schaefer C, Steinmetz H, Sitzer M, Lorenz MW. Clinical usefulness of carotid ultrasound to improve stroke risk assessment: Ten-year results from the Carotid Atherosclerosis Progression Study (CAPS). Eur J Prev Cardiol 2012;22:22.
31. Munger MA, Hawkins DW. Atherothrombosis: Epidemiology, pathophysiology, and prevention. J Am Pharm Assoc 2004;44:S5-S13.
32. Del Bene A, Palumbo V, Lamassa M, Saia V, Piccardi B, Inzitari D. Progressive lacunar stroke: Review of mechanisms, prognostic features, and putative treatments. Int J Stroke 2012;7:321-329.
33. Fisher C. The arterial lesions underlying lacunes. Acta Neuropathol 1969;12:1-15.
34. Markus HS. Genes, endothelial function and cerebral small vessel disease in man. Exp Physiol 2008;93:121-127.